Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that ...

The deal with Tubulis gives Gilead access to the German biotech's ADC technology platform, designed to make ADCs more stable, ...

Cytokinetics should hear back from the FDA next September about its marketing application for aficamten, which is vying to ...

Since the start of the year, Ipsen has bolstered its oncology pipeline with two ADC alliances – with Foreseen Bio and Sutro ...

The Northern Ireland Protocol (NIP) that kept NI within the EU pharma regulatory system was widely derided for failing to ...

Cost-effectiveness agency NICE has recommended NHS use of the therapy – called Kimmtrak (tebentafusp) – for the treatment of ...

Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics ...

In its complaint, BMS alleges that HHS' Health Resources and Services Administration (HRSA), which has responsibility for ...

"A prerequisite for Orexo to succeed with a sophisticated digital health product like Deprexis is a tight collaboration with ...

Alligator – which has developing mitazalimab on its own after losing Johnson & Johnson as a partner for the drug a few years ...

Faced with a cash crunch, Alligator Biosciences has said it plans to shed up to 70% of its workforce and focus all its ...

Venture capital group Abingworth is reportedly trying to raise up to $1.5 billion in investment funding to support biopharma ...